Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris
Clinical trial NCT01600222 · COMPLETED
Trial details
- NCT number
- NCT01600222
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.